Myda Advisors LLC Aptinyx Inc. Transaction History

Myda Advisors LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$1.81 - $5.03 $173,866 - $483,176	-96,059 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.84 - $4.25 $272,807 - $408,250	96,059 New	96,059 $329,000
Q3 2019 Nov 13, 2019	SELL	$3.0 - $4.08 $150,000 - $204,000	-50,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$2.95 - $4.38 $147,500 - $219,000	50,000 New	50,000 $167,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Myda Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Myda Advisors LLC with notifications on news.